CYTK:NASDAQ
Cytokinetics, Inc.
$56.13
arrow_downward
-0.05%(-0.030) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$56.55
High
$56.66
Low
$55.15
Mkt. cap
7.82B
Avg. vol.
2.07M
Volume
1.01M
52-wk high
$88.31
52-wk low
$53.55
EPS
-$6.04
Beta
0.45
Shares outstanding
139.30M
No. of employees
673
Open
$56.55
High
$56.66
Low
$55.15
Mkt. cap
7.82B
Avg. vol.
2.07M
Volume
1.01M
52-wk high
$88.31
52-wk low
$53.55
EPS
-$6.04
Beta
0.45
Shares outstanding
139.30M
No. of employees
673
News stories
From web sources and news partners
Zacks
·
21 hours ago
Can BMY Sustain Growth in Its Cardiovascular Franchise?
Investing.com
·
1 day ago
Cytokinetics director B. Lynne Parshall sells $273,634 in shares
GuruFocus
·
1 day ago
Cytokinetics Inc (CYTK) Director B Parshall Sells 5,000 Shares
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitecytokinetics.com